Agilon Health, Inc.
Agilon Health, Inc. (AGL) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · AGL · as of Jun 8, 2026
Activity summary
Buy transactions
2
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
Agilon Health, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
AGL insider buying and selling by quarter
AGL insider selling · AGL insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · AGL ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
AGL executive sell shares · AGL board member insider trading · AGL insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 1, 2026 | Zamore Denise Chief Legal Officer | Other | 485 | $45K | Form 4 |
| Jun 2, 2026 | Wulf John William Director | Award | 2,133 | — | Form 4 |
| Jun 2, 2026 | WILLIAMS RONALD A Director | Award | 2,133 | — | Form 4 |
| Jun 2, 2026 | McLoughlin Karen Director | Award | 2,133 | — | Form 4 |
| Jun 2, 2026 | MCKENZIE DIANA Director | Award | 2,133 | — | Form 4 |
| Jun 2, 2026 | Mansukani Sharad Director | Award | 2,133 | — | Form 4 |
| Jun 2, 2026 | Battaglia Silvana Director | Award | 2,133 | — | Form 4 |
| May 24, 2026 | Gertsch Timothy CAO | Other | 8 | $691 | Form 4 |
| May 7, 2026 | O'Rourke Timothy Patrick CEO & President · Director | Award | 200,000 | — | Form 4 |
| May 7, 2026 | O'Rourke Timothy Patrick CEO & President · Director | Award | 120,000 | — | Form 4 |
| Apr 14, 2026 | Zamore Denise Chief Legal Officer | Other | 20 | $454 | Form 4 |
| Apr 15, 2026 | Zamore Denise Chief Legal Officer | Other | 220 | $6K | Form 4 |
| Apr 14, 2026 | Venkatachaliah Girish CTO | Other | 96 | $2K | Form 4 |
| Apr 15, 2026 | Venkatachaliah Girish CTO | Other | 330 | $9K | Form 4 |
| Apr 14, 2026 | Gertsch Timothy CAO | Other | 25 | $567 | Form 4 |
| Apr 15, 2026 | Gertsch Timothy CAO | Other | 122 | $3K | Form 4 |
| Apr 14, 2026 | Shaker Benjamin Chief Markets Officer | Other | 104 | $2K | Form 4 |
| Apr 15, 2026 | Shaker Benjamin Chief Markets Officer | Other | 571 | $15K | Form 4 |
| Apr 1, 2026 | Schwaneke Jeffrey A. CFO | Award | 75,000 | — | Form 4 |
| Apr 1, 2026 | Schwaneke Jeffrey A. CFO | Other | 1,662 | $16K | Form 4 |
| Apr 1, 2026 | Shaker Benjamin Chief Markets Officer | Award | 70,000 | — | Form 4 |
| Apr 1, 2026 | Shaker Benjamin Chief Markets Officer | Other | 1,664 | $16K | Form 4 |
| Apr 1, 2026 | Gertsch Timothy CAO | Award | 10,000 | — | Form 4 |
| Apr 1, 2026 | Gertsch Timothy CAO | Other | 266 | $3K | Form 4 |
| Apr 1, 2026 | Venkatachaliah Girish CTO | Award | 28,000 | — | Form 4 |
O'Rourke Timothy Patrick
CEO & President · Director
Date
May 7
Shares
200,000
Price
—
Value
—
O'Rourke Timothy Patrick
CEO & President · Director
Date
May 7
Shares
120,000
Price
—
Value
—
Shaker Benjamin
Chief Markets Officer
Date
Apr 14
Shares
104
Price
$22.68
Value
$2K
Shaker Benjamin
Chief Markets Officer
Date
Apr 15
Shares
571
Price
$26.88
Value
$15K
Shaker Benjamin
Chief Markets Officer
Date
Apr 1
Shares
1,664
Price
$9.75
Value
$16K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About AGL insider trading
AGL insider trades
Agilon Health, Inc. (AGL) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Zamore Denise (Chief Legal Officer), Gertsch Timothy (CAO), Shaker Benjamin (Chief Markets Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. AGL insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Agilon Health, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
AGL insider trading · 5 questionsThe insiders of Agilon Health, Inc. (AGL) include executives and directors such as Zamore Denise (Chief Legal Officer), Gertsch Timothy (CAO), Shaker Benjamin (Chief Markets Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026